Personalized Cancer Vaccine Research

How personalized neoantigen and mRNA therapeutic cancer vaccines work, where clinical research stands, and why promise should not be confused with approval.

Illustrative personalized cancer vaccine research
Illustrative image; not a real product or approved treatment.

What does “cancer vaccine” mean?

Many therapeutic cancer vaccines are designed to stimulate immunity against an existing tumor rather than prevent an infection. Personalized approaches can sequence a patient's tumor, select tumor-specific neoantigens and encode selected targets in mRNA or peptides.

Research status in 2026

The U.S. National Cancer Institute lists active early-phase studies evaluating personalized vaccines in several tumor settings. Active research does not mean a treatment is approved or proven for routine use.

Sources

NCI: mRNA-based personalized cancer vaccine mRNA-4157
NCI: active personalized vaccine phase I trial

Building a science-led brand?

abdibio.com is a short, memorable .com suitable for international chemistry, pharma and biotechnology ventures.

Make an offer